Skip to main content
. 2018 Feb 22;13(2):e0192227. doi: 10.1371/journal.pone.0192227

Fig 1. Kaplan-Meier curve of progression-free survival for nivolumab-treated patients with advanced non-small cell lung cancer.

Fig 1